During the establishment of T2D, DDAH (the enzyme that metabolizes the endogenous competitive inhibitor of NOS enzymes, ADMA) activity decreased by about 44% in the abdominal aorta of T2D rats. The gene discussed is NOS1; the disease is type 2 diabetes mellitus.